| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/06/1992 | CA2087853A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | CA2087836A1 Acetylene derivatives having lipoxygenase inhibitory activity |
| 02/06/1992 | CA2086546A1 Novel substituted thiazolyl and substituted pyridinyl derivatives |
| 02/05/1992 | EP0469833A1 N-Benzyl-Indoles, processes for their preparation and pharmaceutical compositions containing them |
| 02/05/1992 | EP0469477A1 Antiallergic combination |
| 02/05/1992 | EP0469206A1 Hypoallergenic milk products and process of making |
| 02/05/1992 | EP0469200A1 Lactic acid drink and process for the production of the same |
| 02/05/1992 | EP0468971A1 Novel benzimidazole derivatives |
| 02/05/1992 | CN1058404A Derivatives of benzimidazole, their preparation, and their use as medicaments |
| 02/05/1992 | CN1058403A Process for preparing 6-(substituted aminopropionyl) derivatives of forskolin |
| 02/05/1992 | CN1058397A Derivatives of 1-diphenylmethyl piperazine, their preparation and their use as medicaments |
| 02/04/1992 | WO1992002547A1 Method for treating immune system dysfunctions |
| 02/04/1992 | WO1992002220A1 Tnf inhibitors |
| 02/04/1992 | US5086180 Sulphamoylthiophenes, a process for their preparation |
| 02/04/1992 | US5086170 Cyclooxygenase inhibitors antibiotics |
| 02/04/1992 | US5086065 Leukotriene antagonists |
| 02/04/1992 | US5086062 Inhibitors of lipoxygenase and-or cyclooxygenase enzymes |
| 02/04/1992 | US5086056 Treating allergic diseases |
| 02/04/1992 | US5086050 With acetic, gluconic, lactic or malic acids, administering |
| 02/04/1992 | CA2088679A1 Method for treating immune system dysfunctions |
| 02/04/1992 | CA2088352A1 Tnf inhibitors |
| 02/04/1992 | CA1295336C2 Synthetic intermediates for preparing substituted di-t-butylphenols |
| 02/03/1992 | WO1992002253A1 INTERLEUKIN-4 AND INTERLEUKIN-1β SYNERGISTICALLY INDUCE VCAM-1 |
| 02/03/1992 | CA2048236A1 Antiallergic combination |
| 02/02/1992 | WO1992002519A1 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids |
| 02/02/1992 | CA2088355A1 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids |
| 01/30/1992 | DE4024345A1 Cyclopentenderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentene derivatives, processes for their preparation and their pharmaceutical use |
| 01/29/1992 | EP0468885A1 1-Diphenylmethylpiperazine derivatives, their preparation, their use as medicines |
| 01/29/1992 | EP0468884A1 Benzimidazole derivatives, their preparation and their application as medicaments |
| 01/29/1992 | EP0468785A2 (Quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| 01/29/1992 | EP0468445A1 Process for preparation of 6-(substituted-aminopropionyl)-derivates of forskolin |
| 01/29/1992 | EP0468443A1 Process for the preparation of 6-[3-substituted-aminopropionyl]-7-deacetylforskolin derivatives |
| 01/29/1992 | EP0468281A1 Substituted phenylacetylenes, pharmaceuticals containing them and methods for the preparation of these compounds and pharmaceuticals |
| 01/29/1992 | EP0468049A1 Monoclonal antibodies for recognizing a peptide linked to a major histocompatibility antigen |
| 01/29/1992 | EP0467895A1 Dihydropyridine antiallergy agents |
| 01/29/1992 | CN1058216A Substituted thiazolyl and substituted pyridinyl derivatives |
| 01/29/1992 | CN1058215A Oxazolyl derivatives |
| 01/29/1992 | CN1058214A 1,3-oxathiolane nucleoside analogues |
| 01/29/1992 | CN1058148A Method of treatment of allergic conjunctivitis |
| 01/29/1992 | CN1015334B Preparation method for derivertives |
| 01/28/1992 | WO1992002494A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
| 01/28/1992 | US5084575 Drugs for the treatment of rhinitis, asthma and skin disorders |
| 01/28/1992 | US5084386 Production of beta-1,3-glucan in euglena |
| 01/28/1992 | US5084214 Compounds for the treatment of artheriosclerosis |
| 01/28/1992 | CA2088159A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
| 01/28/1992 | CA1295085C Heptanoyl-glu-asp-ala-amino acid immunostimulants |
| 01/28/1992 | CA1294975C Substituted biphenyl derivatives |
| 01/28/1992 | CA1294972C 7-oxabicyclo(2.2.1)heptane-based derivatives |
| 01/28/1992 | CA1294971C Benzofurannic derivatives, process for preparing such and medicated compoundsand cosmetics containing said derivatives |
| 01/28/1992 | CA1294960C 7-deazaguanines as immunomodulators |
| 01/28/1992 | CA1294872C Human complement factors and their therapeutic use |
| 01/27/1992 | CA2047880A1 Benzimidazole derivatives, their preparation and pharmacological applications |
| 01/27/1992 | CA2047879A1 1-diphenylmethylpiperazine derivatives, their preparation and pharmacological applications |
| 01/27/1992 | CA2043823A1 Substituted phenylacetylenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 01/26/1992 | WO1992001465A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 01/26/1992 | CA2087979A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 01/25/1992 | WO1992001684A1 3-(1-substitutedpyrazoyl)-2-oxindole derivatives |
| 01/25/1992 | CA2047940A1 Process for the preparation of 6-(3-substitutedaminopropionyl)-7-deacetylforskolin derivatives |
| 01/25/1992 | CA2047617A1 Process for the preparation of 6-(substitutedaminopropionyl)-derivatives of forskolin |
| 01/24/1992 | CA2047540A1 Continuous release pharmaceutical compositions |
| 01/23/1992 | WO1992001054A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 01/23/1992 | WO1992001049A2 Cd53 cell surface antigen and use thereof |
| 01/23/1992 | WO1992000980A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 01/23/1992 | WO1992000960A1 Beta-alethine use in cell culture and therapy |
| 01/23/1992 | WO1992000955A1 Vitaletheine and use in cell culture and therapy |
| 01/23/1992 | WO1992000756A1 Immune suppressive product |
| 01/23/1992 | WO1992000727A1 Autobiotics and their use in eliminating nonself cells in vivo |
| 01/23/1992 | CA2086513A1 Autobiotics and their use in eliminating nonself cells in vivo |
| 01/22/1992 | EP0467701A2 Cyclic HIV principal neutralizing determinant peptides |
| 01/22/1992 | EP0467699A2 Cyclic HIV principal neutralizing determinant peptides |
| 01/22/1992 | EP0467606A1 Rapamycin derivatives |
| 01/22/1992 | EP0467369A2 Use of furosemide to treat allergic conjunctivitis |
| 01/22/1992 | EP0467280A1 Novel spergualin-related compound and use thereof |
| 01/22/1992 | EP0467248A2 Pyrazolopyridine compound and processes for preparation thereof |
| 01/22/1992 | EP0467116A1 Dermatological compositions containing cis-urocanic acid |
| 01/22/1992 | EP0466838A1 Novel lipid a derivatives and uses therefor |
| 01/22/1992 | CN1058021A 9-purinyl phosphonic acid derivatives |
| 01/22/1992 | CN1058020A Noberastine citrate |
| 01/21/1992 | US5082839 Platelet activating factor antagonist |
| 01/21/1992 | US5082838 Antiinflammatory, immune diseases |
| 01/21/1992 | US5082833 Reduction of cell proliferation and enhancement of nk-cell activity |
| 01/21/1992 | CA2047419A1 Method of treatment of allergic conjunctivitis |
| 01/21/1992 | CA2047341A1 Spergualin-related compound and use thereof |
| 01/21/1992 | CA1294549C Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug |
| 01/20/1992 | WO1992001687A1 Novel oxazolyl derivatives |
| 01/20/1992 | WO1992001472A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | CA2087541A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | CA2086545A1 Oxazolyl derivatives |
| 01/20/1992 | CA2047078A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047043A1 Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties |
| 01/20/1992 | CA2047042A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047033A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047030A1 Class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties |
| 01/15/1992 | EP0466662A2 6,7-disubstituted-2-aminotetralines active as immunomodulators and pharmaceutical compositions containing same |
| 01/15/1992 | EP0466505A2 Artificial antibody |
| 01/15/1992 | EP0466498A1 Physiologically active peptides having immunoregulatory activities |
| 01/15/1992 | EP0466452A2 Thioxo heterocycles and their pharmaceutical use |
| 01/15/1992 | EP0466365A2 Novel immunosuppressant fermentation products of a microorganism |
| 01/15/1992 | EP0466037A2 Process for enhancing the resistance of aquatic animals to disease |
| 01/15/1992 | EP0465529A1 Expression of exogenous polynucleotide sequences in a vertebrate |